Abstract:OBJECTIVE: It has been reported that there are differences between in vitro and in vivo matured oocytes for their survival rates following vitrification The purpose of this study is to determine the competency of cryodamage resistance of in vitro matured oocytes in the presence of cysteamine during in vitro maturation (IVM).DESIGN: Animal-model study.MATERIALS AND METHODS: Female mice (CD-1) were stimulated with 10IU PMSG. Oocytes were collected after 48h and the collected oocytes were divided into following groups: (1) Cumulus-oocyte-complex (COC); (2) denuded groups. Both COC and denuded oocytes were cultured in IVM medium containing 75mIU/mL FSH and LH, 10% FBS for 16 h in the presence or absence of cysteamine (200μM). Following culture, the maturated oocytes were either vitrified or inseminated immediately. Vitrification and thawing procedures were performed with McGill Cryoleaf as reported previously. Vitrified oocytes were thawed and inseminated on the other day. Fertilization rate were recorded 24 h after insemination, and early embryonic development were assessed. Statistical differences were considered significant at p<0.05.RESULTS: The presence of cysteamine during IVM significantly increased maturation rate in COC group but had no significant difference in denuded group. The presence of cyseamine during IVM does not improve the survival rate of in vitro matured oocytes with or without cumulus cells during IVM. However, the presence of cumulus cells during IVM had better fertilization rate (p<0.05) compared to the denuded oocytes after vitrification-thawing. The presence of cysteamine during IVM significantly reduced the fragmentation rate in cumulus-intact group compared to cumulus-free group following vitrification-thawing.CONCLUSIONS: The presence of cysteamine during IVM has beneficial effect on both COC and denuded oocytes in terms of their competency of subsequent fertilization and early embryonic development following vitrification. OBJECTIVE: It has been reported that there are differences between in vitro and in vivo matured oocytes for their survival rates following vitrification The purpose of this study is to determine the competency of cryodamage resistance of in vitro matured oocytes in the presence of cysteamine during in vitro maturation (IVM). DESIGN: Animal-model study. MATERIALS AND METHODS: Female mice (CD-1) were stimulated with 10IU PMSG. Oocytes were collected after 48h and the collected oocytes were divided into following groups: (1) Cumulus-oocyte-complex (COC); (2) denuded groups. Both COC and denuded oocytes were cultured in IVM medium containing 75mIU/mL FSH and LH, 10% FBS for 16 h in the presence or absence of cysteamine (200μM). Following culture, the maturated oocytes were either vitrified or inseminated immediately. Vitrification and thawing procedures were performed with McGill Cryoleaf as reported previously. Vitrified oocytes were thawed and inseminated on the other day. Fertilization rate were recorded 24 h after insemination, and early embryonic development were assessed. Statistical differences were considered significant at p<0.05. RESULTS: The presence of cysteamine during IVM significantly increased maturation rate in COC group but had no significant difference in denuded group. The presence of cyseamine during IVM does not improve the survival rate of in vitro matured oocytes with or without cumulus cells during IVM. However, the presence of cumulus cells during IVM had better fertilization rate (p<0.05) compared to the denuded oocytes after vitrification-thawing. The presence of cysteamine during IVM significantly reduced the fragmentation rate in cumulus-intact group compared to cumulus-free group following vitrification-thawing. CONCLUSIONS: The presence of cysteamine during IVM has beneficial effect on both COC and denuded oocytes in terms of their competency of subsequent fertilization and early embryonic development following vitrification.

Evaluation of the Developmental Potential of Metaphase I Oocytes from Stimulated Intracytoplasmic Sperm Injection Cycles

The developmental competence of human metaphase I oocytes with delayed maturation in vitro

Improved Developmental Competence and Spindle Assembly of in Vitro Maturation of Human Oocytes by Prolonged Culture Duration

Can Sperm-Injected In-Vitro Matured (IVM) Oocytes Produce Viable Pregnancies?

The Effect of Antioxidant Agent During in Vitro Maturation (IVM) of Murine Oocytes on Survival, Fertilization and Early Embryonic Development Following Vitrification

The influence of oocyte maturation on embryo development and clinical outcomes in intracytoplasmicsperm injection cycles

SORT-TERM <i>IN VITRO</i> MATURATION (IVM) CULTURE OF CUMULUS-OOCYTE COMPLEXES IMPROVES SUBSEQUENT EMBRYONIC DEVELOPMENT IN STIMULATED CYCLES.

In vitro Maturation of Human Oocytes Discarded after Intracytoplasmic Sperm Injection Treatment and Parthenogenetic Activation

In-vitro maturation culture and vitrification of immature oocytes

Fertilization of in Vitro Matured Human Oocytes by Intracytoplasmic Sperm Injection （ICSI） Using Ejaculated and Testicular Spermatozoa

Effect of Different Single Sperm Injection Method for ICSI on in vitro Development of Embryos

Compare ICSI results of immature oocytes from IVM cycles with IVF-ICSI cycles

Sperm penetration at the maturing metaphase I stage can trigger oocyte activation in a mouse model

A Prospective Randomized Controlled Trial: Short-Time in Vitro Maturation for Improvement of Oocytes Quality and Reproductive Outcomes

Influence of the rate of MⅡ oocyte and dominant follicles on HCG-day on the outcomes during intracytoplasmic sperm injection and embryo transfer procedure

[In Vitro Maturation--n Vitro Fertilization--embryo Transfer--frozen-thawed of Human Oocytes].

Study on the Developmental Competence of Vitrified Bovine Oocytes Following Intracytoplasmic Sperm Injection

Chromosomal Aberrations in In-Vitro Matured Oocytes Influence Implantation and Ongoing Pregnancy Rates in a Mouse Model Undergoing Intracytoplasmic Sperm Injection.

[The Evaluation of 156 Cycles of Intracytoplasmic Sperm Injection in the Management of Male Infertility and Idiopathic Infertility].

Assisted Artificial Activation of Electrical Stimulation on Human Mature Oocytes at Different Ages.

Research on the clinical application of intracytoplasmic sperm injection